局部晚期食管癌治疗模式的研究进展
Treatment Model of Locally Advanced Esophageal Cancer
DOI: 10.12677/WJCR.2022.123014, PDF,   
作者: 段海玲：内蒙古民族大学第二临床医学院，内蒙古 牙克石；曲洪澜*：内蒙古林业总医院，内蒙古 牙克石
关键词: 综合治疗；食管癌；食管癌切除术；Combined Modality Therapy； Esophageal Cancer； Esophagectomy
摘要: 食管癌被诊断时多已处于局部晚期。单独手术的最佳效果较差，综合治疗已被确立为食管癌II~III期的标准治疗。这篇综述重点关注食管癌管理的最新证据，集中描述局部晚期食管癌的各种不同治疗方法的不同差异。主要区别在于诱导治疗的选择。大多数证据支持新辅助放化疗后进行手术治疗鳞状细胞癌和腺癌。
Abstract: Esophageal cancer is usually diagnosed at a locally advanced stage. The best results of surgery alone are poor, and combined therapy has been established as the standard of treatment for stage II~III esophageal cancer. This review focuses on the latest evidence on the management of esophageal cancer and focuses on the differences between different treatments for locally advanced esophageal cancer. The main difference is in the choice of induction therapy. Most evidence supports surgical treatment of squamous cell carcinoma and adenocarcinoma after neoadjuvant chemoradiotherapy.
文章引用：段海玲, 曲洪澜. 局部晚期食管癌治疗模式的研究进展[J]. 世界肿瘤研究, 2022, 12(3): 107-110. https://doi.org/10.12677/WJCR.2022.123014

参考文献

[1] Pennathur, A., et al. (2013) Oesophageal Carcinoma. The Lancet, 381, 400-412.
[Google Scholar] [CrossRef] 
[2] Takeuchi, H., et al. (2014) A Risk Model for Esophagectomy Using Data of 5354 Patients Included in a Japanese Nationwide Web-Based Database. Annals of Surgery, 260, 259-266.
[Google Scholar] [CrossRef] 
[3] Jemal, A., et al. (2008) Cancer Statistics, 2008. CA: A Cancer Journal for Clinicians, 58, 71-96.
[Google Scholar] [CrossRef] 
[4] 张默言, 李勇, 宋朋, 等. 调整食管癌新辅助化疗方案周期以应对特殊时期患者手术延迟的治疗策略探讨[J]. 中华肿瘤杂志, 2021, 43(6): 686-690.
[5] Watanabe, M., et al. (2020) Recent Progress in Multidisciplinary Treatment for Patients with Esophageal Cancer. Surgery Today, 50, 12-20.
[Google Scholar] [CrossRef] [PubMed]
[6] Ando, N., et al. (2012) A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluor- ouracil versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907). Annals of Surgical Oncology, 19, 68-74.
[Google Scholar] [CrossRef] [PubMed]
[7] Kitagawa, Y., et al. (2019) Esophageal Cancer Practice Guidelines 2017 Edited by the Japan Esophageal Society: Part 1. Esophagus, 16, 1-24.
[8] Cunningham, D., et al. (2006) Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. The New England Journal of Medicine, 355, 11-20.
[Google Scholar] [CrossRef] 
[9] Ychou, M., et al. (2011) Perioperative Chemotherapy Compared with Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial. Journal of Clinical Oncology, 29, 1715-1721.
[Google Scholar] [CrossRef] 
[10] Lerut, T. (2018) Neoadjuvant Chemoradiotherapy Followed by Surgery versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus: The (NEOCRTEC5010) Trial—A Timely and Welcome Clinical Trial from the Far East. The Journal of Thoracic Disease, 10, S4162-S4164.
[Google Scholar] [CrossRef] [PubMed]
[11] Teoh, A.Y., et al. (2013) Long-Term Survival Outcomes after Definitive Chemoradiation versus Surgery in Patients with Resectable Squamous Carcinoma of the Esophagus: Results from a Randomized Controlled Trial. Annals of Oncology, 24, 165-171.
[Google Scholar] [CrossRef] [PubMed]
[12] Bedenne, L., et al. (2007) Chemoradiation Followed by Surgery Compared with Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102. Journal of Clinical Oncology, 25, 1160-1168.
[Google Scholar] [CrossRef] 
[13] Sohda, M. and Kuwano, H. (2017) Current Status and Future Prospects for Esophageal Cancer Treatment. Annals of Thoracic and Cardiovascular Surgery, 23, 1-11.
[Google Scholar] [CrossRef] [PubMed]
[14] Nishimura, M., et al. (2007) Salvage Esophagectomy Following Definitive Chemoradiotherapy. General Thoracic and Cardiovascular Surgery, 55, 461-464.
[Google Scholar] [CrossRef] [PubMed]
[15] Kumagai, K., et al. (2016) Systematic Review and Meta-Analysis on the Significance of Salvage Esophagectomy for Persistent or Recurrent Esophageal Squamous Cell Carcinoma after Definitive Chemoradiotherapy. Diseases of the Esophagus, 29, 734-739.
[Google Scholar] [CrossRef] [PubMed]
[16] Burmeister, B.H., et al. (2011) Is Concurrent Radiation Therapy Required in Patients Receiving Preoperative Chemotherapy for Adenocarcinoma of the Oesophagus? A Randomised Phase II Trial. European Journal of Cancer, 47, 354- 360.
[Google Scholar] [CrossRef] [PubMed]
[17] von Dobeln, G.A., Klevebro, F., Jacobsen, A.B., Johannessen, H.O., Nielsen, N.H., Johnsen, G., Hatlevoll, I., Glenjen, N.I., Friesland, S., Lundell, L., Yu, J. and Nilsson, M. (2019) Neoadjuvant Chemotherapy versus Neoadjuvant Chemoradiotherapy for Cancer of the Esophagus or Gastroesophageal Junction: Long-Term Results of a Randomized Clinical Trial. Diseases of the Esophagus, 32.
[Google Scholar] [CrossRef] [PubMed]

为你推荐